Topic
Circulating Tumor DNA (ctDNA)
16 Podcasts • 2 Courses on BackTable
Episode # 132 • 01 Sept 2026
Gynecologic Cancer Surveillance: Best Practices & Updates
Does catching cancer earlier with surveillance always translate to better outcomes for gynecologic cancer patients? On this episode of BackTable, hosts Dr. Mona Guo and Dr. Marcia Ciccone interview Dr. Ritu Salani, Professor of OBGYN at UCLA and lead author of the updated SGO surveillance clinical practice statements. They discuss how post–curative-intent surveillance has evolved amid limited prospective evidence, review the latest guidelines, and highlight the real-world challenges of balancing early detection, patient safety, and cost.
More on Circulating Tumor DNA (ctDNA)
Loading recent podcasts…
Women's Health # 132
Aug 31, 2026
with Dr. Ritu Salani, Dr. Mona Guo, Dr. Marcia Ciccone
Does catching cancer earlier with surveillance always translate to better outcomes for gynecologic cancer patients? On...
Tumor Board # 76
Aug 10, 2026
with Dr. Alan Tan, Dr. Katy Beckermann
Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable...
Tumor Board # 64
Jun 8, 2026
with Dr. Michael Gibson, Dr. Eric Lander
Is personalized, surgery-sparing treatment becoming a reality for patients with gastric adenocarcinoma? In this episode...
Tumor Board # 54
Apr 6, 2026
with Dr. Tyler Stewart, Dr. Jun Gong
Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...
Tumor Board # 79
Aug 31, 2026
with Dr. Ritu Salani, Dr. Mona Guo, Dr. Marcia Ciccone
Does catching cancer earlier with surveillance always translate to better outcomes for gynecologic cancer patients? On...
Tumor Board # 65
Jun 10, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
Urology # 303
May 18, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
1,300+ listens
Urology # 290
Feb 16, 2026
with Dr. Abhinav Khanna, Dr. Daniel Roberson
What do you do when metastatic urothelial cancer responds dramatically to systemic therapy? In this episode of...
1,500+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.